Skip to main content

Newly Diagnosed Solid Tumor

Clinical Pathways promote evidence based, safe, and high-value care for patients by providing clinical recommendations and standard processes. They are developed by multidisciplinary committees of subject matter experts, informed by methodical review of available evidence and consensus among committee members. 

Clinical Pathways:

Inclusion and exclusion criteria:

  • Inclusion:
    • Patients with suspected malignant or newly diagnosed solid tumor in an extremity, renal, suprarenal, liver, retroperitoneal, abdominal (not otherwise specified), thoracic, ovarian/uterine, and testicular locations
  • Exclusion:
    • Patients with suspected anterior mediastinal mass

Committee members involved in the development:

  • Joel Thompson, MD | Hematology/Oncology/BMT | Committee Chair
  • Bhargava Mullapudi, MD | Transplant Surgery | Committee Member
  • Kris Laurence, BHS, CCRP | Hematology/Oncology/BMT | Committee Member
  • Lindsey Fricke, RN, MSN, FNP-BC, CPHON | Hematology/Oncology/BMT | Committee Member
  • Brenton Reading, MD | Radiology| Committee Member
  • John Krumme, MD | Orthopedic Surgery | Committee Member
  • Melissa A. H. Gener, MD, FCAP | Pathology and Laboratory Medicine | Committee Member
  • Eugenio Taboada, MD, FCAP | Pathology and Laboratory Medicine | Committee Member
  • Ashli Lawson, MD | Gynecology | Committee Member
  • Joel Koenig, MD | Urology | Committee Member

EBP Committee Members:

  • Todd Glenski, MD, MSHA, FASA | Anesthesiology, Evidence Based Practice | Committee Member
  • Jarrod Dusin, MS, RD, LD, CPHQ | Evidence Based Practice | Committee Member

Publication dates:

  • Finalized date: 11/2022
  • Next expected revision date: 11/2025

If you have any questions regarding this content or identify a broken link, please email evidencebasedpractice@cmh.edu. 

These pathways do not establish a standard of care to be followed in every case. It is recognized that each case is different, and those individuals involved in providing health care are expected to use their judgment in determining what is in the best interests of the patient based on the circumstances existing at the time. It is impossible to anticipate all possible situations that may exist and to prepare a pathway for each. Accordingly, these pathways should guide care with the understanding that departures from them may be required at times.

Children's Mercy Kansas City   /    Health Care Providers   /    Evidence Based Practice / Clinical Pathways    /    Clinical Practice Guidelines, Care Process Models, and Enhanced Recovery After Surgery Pathways   /   Newly Diagnosed Solid Tumor